Early imaging is key to detecting anomalies, some of which are unique to multiple gestations and some that also occur with singletons. Any anomaly that occurs in singletons can occur in 1 fetus in a multifetal pregnancy.
Early imaging is key to detecting anomalies, some of which are unique to multiple gestations and some that also occur with singletons.
Figure 1. Thick intertwin membrane, first trimester dichorionic gestation.
Figure 2. Difficult-to-identify intertwin membrane, first trimester monochorionic gestation.
Figure 3. Second trimester twin peak sign, indicating dichorionicity.
Figure 4. Second trimester twin peak sign, indicating dichorionicity.
Figure 5. Second trimester twin peak sign, indicating dichorionicity.
Figure 6. Second trimester T-sign, indicating monochorionicity.
Figure 7. Second trimester T-sign, indicating monochorionicity.
Figure 8. Thick membrane in all 3 intertwin membranes at their juncture in the center of the uterine cavity (ipsilon sign) confirms first trimester trichorionic triplets.
Figure 9. Polyhydraminos in twin-to-twin transfusion syndrome, second trimester.
Figure 9B. The recipient fetus, left, moving freely throughout the uterine cavity. The donor fetus, right, remains in the same position.
Figure 9C. Intertwin membrane, often seen only when scanning close to the donor twin near flexed joints – neck, axillae, and hips.
Figure 10. Second trimester monoamniotic twins, umbilical cord entanglement visible on color Doppler examination.
Figure 11. First trimester conjoined twins. Sagittal view shows 2 cephalic poles, right. Note that the upper cephalic pole could be misinterpreted as a large omphalocele of a single fetus.
Figure 11B. Axial view showing a point at which the 2 fetuses are separated.
Figure 12. Early second trimester twin reversed arterial perfusion sequence showing the amorphous acardiac fetal mass.
Figure 12B. Color Doppler examination shows umbilical cord of the amorphous acardiac mass, with blood flow.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Prenatal SSRI or SNRI discontinuation not linked to adverse psychiatric outcomes
October 8th 2024In a recent study, similar rates of adverse psychiatric-related outcomes were reported among patients with discontinuation of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors vs those without discontinuation.
Read More
Tailored hormone therapy improves postoperative endometriosis outcomes
October 3rd 2024A recent study suggests that postoperative endometriosis patients experience improved quality of life through hormone therapies guided by optimizing treatment based on individual hormonal receptor profiles.
Read More